fbpx

Pulmonx Reports Scientific Publication and Presentations Highlighting Key Advances in Emphysema Treatment

  • Posted by Chris Kellett
  • On September 27, 2010
September 27, 2010, Neuchâtel, Switzerland – Pulmonx, an emerging leader in interventional pulmonology, announced today that the New England Journal of Medicine has published the results of the largest prospective, randomized, controlled study completed to date of endobronchial approaches to emphysema treatment, the VENT Study (Endobronchial Valve for Emphysema PalliatioN Trial).
Read More

Pulmonx Raises $32 Million for Launch of Emphysema Products

  • Posted by Chris Kellett
  • On February 22, 2010
ences Rollout of Breakthrough New Products Redwood City, CA USA (February 22, 2010) – Pulmonx, an emerging leader in interventional pulmonology, announced today that it has concluded an agreement for a new round of equity financing from an investment syndicate led by two new investors. The company also announced that it plans to use this capital to support the international commercial launch of its Zephyr®Endobronchial Valve (EBV), and its recently approved Chartis® Pulmonary Assessment System.
Read More